Patents by Inventor Jürgen Zeidler

Jürgen Zeidler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6787157
    Abstract: A solid or semisolid, at least two-phase active ingredient-containing formulation in which there is multiparticulate incorporation of one of the two phases into a matrix of the other phase, and at least one of the phases contains at least one active ingredient, obtainable by introducing particles of one phase into the other phase in a plastic state, and shaping the material while still plastic.
    Type: Grant
    Filed: March 10, 1998
    Date of Patent: September 7, 2004
    Assignee: Abbott Laboratories
    Inventors: Joerg Rosenberg, Jürgen Zeidler, Jörg Breitenbach, Gunther Berndl, Andreas Kleinke
  • Patent number: 6547997
    Abstract: Solvent-free noncrystalline bioactive substances are prepared from the corresponding crystalline bioactive substances in an extruder by melting the substances in the extruder under reduced pressure and in the absence of auxiliaries, cooling and comminuting.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: April 15, 2003
    Assignee: Abbot Laboratories
    Inventors: Jörg Breitenbach, Ulrich Reinhold, Jürgen Zeidler, Jörg Rosenberg
  • Patent number: 6488939
    Abstract: Solid, elongate dosage forms (10) with a long axis (11) and with a length (L) which is defined by projection of the ends (12, 13) of the dosage form to the long axis, where a cross-sectional area (14, 15, 16) oriented perpendicular to the long axis (11) has an area which is variable along the long axis (11) and increases from a cross-sectional area (15) which is located between the ends (12, 13) and has a minimal area essentially continuously toward the two ends (12, 13) up to in each case a cross-sectional area (14 and 16 respectively) with a maximal area, wherein the distance of the maximal cross-sectional area (14) which is located near one end (12) from the maximal cross-sectional area (16) which is located near the other end (13) is, projected on the long axis (11), more than half the length (L) of the dosage form (10), are described.
    Type: Grant
    Filed: May 31, 2001
    Date of Patent: December 3, 2002
    Assignee: Abbott Laboratories
    Inventors: Jürgen Zeidler, Jörg Rosenberg, Werner Maier, Jörg Neumann
  • Patent number: 6322816
    Abstract: A fast-acting analgesic comprises as analgesic substance ibuprofen in an adjuvant matrix with a porous structure and a density of greater than 1 and up to 2.5 g/cm3.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: November 27, 2001
    Assignee: BASF Aktiengesellschaft
    Inventors: Jürgen Zeidler, Jörg Neumann, Bernd Leipold, Jörg Rosenberg, Gunther Berndl, Jörg Breitenbach, Christiane Vollgraf
  • Patent number: 6187342
    Abstract: The invention relates to solid drug forms obtainable by extrusion with subsequent shaping of a solvent-free melt, comprising, besides one or more active ingredients, A) 10-90% by weight of a melt-processable, water-soluble polymer, B) 5-85% by weight of isomalt, and C) 0-5% by weight of lecithin, where the total of all the ingredients is to be equal to 100% by weight.
    Type: Grant
    Filed: February 24, 1998
    Date of Patent: February 13, 2001
    Assignee: BASF Aktiengesellschaft
    Inventors: Jürgen Zeidler, Joerg Rosenberg, Jörg Neumann, Jörg Breitenbach